Lantheus Medical Imaging, Inc. - Strategic SWOT Analysis Review
- provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.Scope
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
Lantheus Medical Imaging, Inc. (Lantheus Medical), formerly Bristol-Myers Squibb Medical Imaging, Inc., develops, manufactures, and commercializes medical imaging agents. Its major products include medical radiopharmaceuticals (including technetium generators) and contrast agents. The company’s products are used for the diagnosis of cardiovascular and other diseases by nuclear physicians, cardiologists, radiologists, internal medicine physicians, technologists and sonographers. Its products are used in the diagnoses of coronary artery disease, congestive heart failure, stroke, peripheral vascular disease, pulmonary function, imaging of lungs and aortoiliac occlusive disease. The company offers its products through its own sales offices in the domestic market and through third party distributors in Europe, Asia Pacific and Latin America. It operates in the US, Puerto Rico, Canada, and Australia. Lantheus Medical is headquartered in Massachusetts, the US.
Lantheus Medical Imaging, Inc. Key Recent Developments
May 05, 2015: Lantheus Medical Imaging Reports 2015 First Quarter Financial Results
May 04, 2015: Results From Lantheus Medical Imaging's First Phase 3 Study of Novel PET Cardiac Imaging Agent Flurpiridaz F 18 Presented at ICNC12
Mar 16, 2015: Lantheus Medical Imaging Promotes Mary Anne Heino to Chief Operating Officer
Mar 04, 2015: Lantheus Medical Imaging Reports 2014 Fourth Quarter and Full Year Financial Results
Jan 29, 2015: Lantheus Medical Imaging Announces FDA Approval of Jubilant HollisterStier as a New Manufacturing Site for NEUROLITEReasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Some sections may be missing if data is unavailable for the company.